These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7715856

  • 1. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity.
    Widzowski DV, Finkelstein JN, Pokora MJ, Cory-Slechta DA.
    Neurotoxicology; 1994; 15(4):853-65. PubMed ID: 7715856
    [Abstract] [Full Text] [Related]

  • 2. Functional alterations in dopamine systems assessed using drug discrimination procedures.
    Cory-Slechta DA, Widzowski DV, Pokora MJ.
    Neurotoxicology; 1993; 14(2-3):105-14. PubMed ID: 8247385
    [Abstract] [Full Text] [Related]

  • 3. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
    Zuch CL, O'Mara DJ, Cory-Slechta DA.
    Toxicol Appl Pharmacol; 1998 May; 150(1):174-85. PubMed ID: 9630467
    [Abstract] [Full Text] [Related]

  • 4. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.
    Kala SV, Jadhav AL.
    Neurotoxicology; 1995 May; 16(2):297-308. PubMed ID: 7566689
    [Abstract] [Full Text] [Related]

  • 5. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
    Cory-Slechta DA, Pokora MJ, Fox RA, O'Mara DJ.
    Neurotoxicology; 1996 May; 17(2):445-57. PubMed ID: 8856740
    [Abstract] [Full Text] [Related]

  • 6. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
    Choi SJ, Mazzio E, Kolta MG, Soliman KF.
    Ann N Y Acad Sci; 1998 May 30; 844():293-302. PubMed ID: 9668686
    [Abstract] [Full Text] [Related]

  • 7. Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure.
    Lasley SM.
    Neurotoxicology; 1992 May 30; 13(3):625-35. PubMed ID: 1361980
    [Abstract] [Full Text] [Related]

  • 8. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth.
    El-Khodor BF, Boksa P.
    Exp Neurol; 1997 May 30; 145(1):118-29. PubMed ID: 9184115
    [Abstract] [Full Text] [Related]

  • 9. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA, O'Mara DJ, Brockel BJ.
    J Pharmacol Exp Ther; 1998 Aug 30; 286(2):794-805. PubMed ID: 9694936
    [Abstract] [Full Text] [Related]

  • 10. Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain.
    Bortolozzi AA, Evangelista De Duffard AM, Duffard RO, Antonelli MC.
    Neurotoxicol Teratol; 2004 Aug 30; 26(4):599-605. PubMed ID: 15203183
    [Abstract] [Full Text] [Related]

  • 11. Homogeneity of regional brain lead concentrations.
    Widzowski DV, Cory-Slechta DA.
    Neurotoxicology; 1994 Aug 30; 15(2):295-307. PubMed ID: 7991218
    [Abstract] [Full Text] [Related]

  • 12. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity.
    Cory-Slechta DA.
    Neurotoxicology; 1997 Aug 30; 18(3):673-88. PubMed ID: 9339816
    [Abstract] [Full Text] [Related]

  • 13. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 14. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 10; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 15. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
    Pokora MJ, Richfield EK, Cory-Slechta DA.
    J Neurochem; 1996 Oct 10; 67(4):1540-50. PubMed ID: 8858938
    [Abstract] [Full Text] [Related]

  • 16. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens.
    Goeders NE, Kuhar MJ.
    Alcohol Drug Res; 1987 Oct 10; 7(4):207-16. PubMed ID: 2950865
    [Abstract] [Full Text] [Related]

  • 17. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR, Brockel BJ, Pankevich DE, Virgolini MB, Cory-Slechta DA.
    Neurotoxicology; 2003 Mar 10; 24(2):227-43. PubMed ID: 12606295
    [Abstract] [Full Text] [Related]

  • 18. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
    Mukda S, Kaewsuk S, Ebadi M, Govitrapong P.
    Dev Neurosci; 2009 Mar 10; 31(3):193-201. PubMed ID: 19145071
    [Abstract] [Full Text] [Related]

  • 19. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 10; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.
    Nye HE, Hope BT, Kelz MB, Iadarola M, Nestler EJ.
    J Pharmacol Exp Ther; 1995 Dec 10; 275(3):1671-80. PubMed ID: 8531143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.